SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.05.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | Roche overweight | JP Morgan Chase & Co. | |
| 29.04.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche Neutral | Citigroup Corp. | |
| 28.04.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.04.15 | Novartis Hold | Deutsche Bank AG | |
| 24.04.15 | Novartis Outperform | Credit Suisse Group | |
| 24.04.15 | Roche Neutral | UBS AG | |
| 23.04.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.04.15 | Novartis buy | S&P Capital IQ | |
| 22.04.15 | Roche Hold | S&P Capital IQ | |
| 22.04.15 | Roche kaufen | Independent Research GmbH | |
| 21.04.15 | Novartis Outperform | BNP PARIBAS | |
| 21.04.15 | Roche Outperform | Bernstein Research | |
| 21.04.15 | Novartis Outperform | Bernstein Research | |
| 21.04.15 | Roche Neutral | UBS AG | |
| 17.04.15 | Roche buy | Deutsche Bank AG | |
| 16.04.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 16.04.15 | Roche buy | Société Générale Group S.A. (SG) | |
| 14.04.15 | Novartis neutral | Independent Research GmbH | |
| 14.04.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.04.15 | Novartis buy | UBS AG | |
| 13.04.15 | Novartis buy | Jefferies & Company Inc. | |
| 13.04.15 | Roche overweight | JP Morgan Chase & Co. | |
| 10.04.15 | Roche kaufen | Independent Research GmbH | |
| 08.04.15 | Roche Neutral | UBS AG | |
| 08.04.15 | Novartis buy | UBS AG | |
| 07.04.15 | Roche Neutral | Citigroup Corp. | |
| 01.04.15 | Novartis Equal weight | Barclays Capital | |
| 01.04.15 | Roche overweight | Barclays Capital | |
| 31.03.15 | Roche Outperform | Credit Suisse Group | |
| 31.03.15 | Roche overweight | JP Morgan Chase & Co. | |
| 04.03.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.15 | Roche Outperform | BNP PARIBAS | |
| 04.03.15 | Novartis Outperform | BNP PARIBAS | |
| 03.03.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.03.15 | Novartis buy | UBS AG | |
| 23.02.15 | Roche Neutral | UBS AG |